This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
From one viewpoint, Home Depot (NYSE:HD) is a slam-dunk buy. After all, there’s a school of thought that investing simply comes down to owning the best businesses and holding them for the long-term. As Warren Buffett put it, “It’s far better to own a wonderful business at a fair price than a fair business at wonderful price.” And it’s hard to argue that Home Depot isn’t a wonderful business.
LOW HD AMZN LEN DHI MHK AMWD
Wall Street doesn’t always get it right, but analysts’ track record is better than some skeptics suggest. And when the Street as a whole is arguing for big upside, investors should at least consider what those analysts have to say.
LRCX ARNC.PR HA TEVA ARNC.PRB AA.PRB MFIN GTN.A CMN AMAT HMNY CELG QUAD AA TRBAB MHO FOX SBNY AMC HXSCF AAL TMUS TRBNW VRX CMD ARNC MDT GTN MHK FOXA AMWD SBGI HXSCL MFINL OLED LEN MDCO TEVVF NFLX CXO WGO CHTR AAI RSPP AAPL DAL DIS LUV DISH SBNYW CMCSA THO NYTAB S XRAY TEVJF MU AA.PR DHI TRCO
Mohawk Industries is a Georgia-based company that designs, manufactures, and distributes flooring products such as tiles, carpets, rugs, hardwood flooring, and so on.
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?
begin 644 MHK20.8A.05.30.18.2.pdf M)5!$1BTQ+C,*)79E
Ruane, Cunniff & Goldfarb’s 13F portfolio value decreased ~11% from $12.20B to $10.91B. The number of positions decreased from 66 to 59.
NPSNY BMCH KMX COF.WS RYCEY CAXPF TJX AMZN STCK VIVHY OMC AABA RYCEF BLDR SCHW.PRBCL COF-P IAC WSCC SEQUX BRK.A PRI GOOGL MHK FCAU JD COF.PRG WFCNP COF.PRH FB IBKR WUBA WFC.PRL COF.PRP WFC.PRJ GOOG COF-D WFC.PRT GS COF-C COF-F WFC.PRR WFC.PRQ JEC WFC.PRP WFC.PRO WFC.PRN WFC.PRY COF.PRC WFC.PRX COF.PRD WFC.PRW WFC.PRV CNSWF COF.PRF WFC LBRDB WFC.WS WSBF MA COF LBRDK FWONA W V BKNG SCHW XRAY CACC FWONK WAT LBRDA ORLY
Glenview Capital Management’s 13F portfolio value decreased from $18.50B to $17.10B this quarter. The number of positions decreased from 58 to 52.
LOW ATHTF FLEX LBTY KMI.WS WBA ENL CVS HPE SHPG NWL LBTYK KMI.PRA KMI LILAB HCA WMB DOW MTOR CAH KMR DXC AET CVB CMCSK IQV ABBV EBAY EBAYL PNR MIK TMUSP WP TMUS BKD UHS CBS.WD CAR VER CNDT GOOGL LILAK RLGY ABBV CPV MHK ESRX TLRD ENDP LH FB DNB PAH TMO CCV MCK KDNUU CCZ GOOG DLPH AGN CCE AAPL MON CI ARMK CBS CSC CBS.A LYB CMCSA FTI.WI FMC LBTYB LBTYA FDX ANTM HUM DWDP KND ABC V CCV.CL FDC LALWF THC KMRFZ HTZ APTV ANTX LILA
Document UNITED STATES
Dan Loeb's 13F portfolio value decreased from $13.86B to $13.32B this quarter. The number of positions decreased from 44 to 40.
PCG ATHTF STZ.B TWX CVS CRM SHW GGAL HON AABA AVGO DOW DOV MELI MAC AET MMM PBF GD TPRE WP KDMN UTX STZ BKI TWC BABA DVMT GOOGL MSFT APY MHK QCOM GRBK MGM FB DOV.WI LEN NXPI PAM PE NFLX PF GOOG BAX LEN.B MPC PAGS ADBE SPGI RSPP VMC MON ICE SWN HON EA WYNN LYB FTI.WI FMC ANTM DWDP BID NEXA BLK XRAY T SUPV DHR ANTX
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to MHK / Mohawk Industries, Inc. on message board site Silicon Investor.
|MHK - Mohawk||Mohawk, MHK a Consumer Cyclical star|
as of ET